Medtronic (MDT) Reports Strong Q4 with $36 Billion Revenue Growth

Medtronic (MDT) recorded fiscal 2026 revenue of $36.36 billion, an 8.43% increase year-over-year. The company raised its quarterly dividend to $0.72, yielding approximately 3.52%, marking 49 consecutive years of increases. Trading at 14 times forward earnings, MDT demonstrates defensive value due to its non-discretionary medical procedures and a beta of 0.597. Key risks include a $185 million tariff and 230-basis-point margin compression, but underlying demographics may support long-term growth.